Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for post-exposure prevention of COVID-19 in home-quarantined adults
MOH_2020-05-05_008846Phase 3Not yet recruiting
- Sponsor
- פרופ אלון מוזס
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Plaquenil with Placebo (2 arms). Primary endpoint: Primary endpoint not reported. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on MOH_2020-05-05_008846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-05-05_008846.